Skip to main content

Gluteal Myomodulation® · Clinical assessment

Contraindications & Clinical Restrictions

Know when to stop, when to postpone, and when to assess more closely.

Before planning gluteal Myomodulation® with Endopeel®, assess the patient’s medical history, local anatomy, previous procedures and intended change in contour. Distinguish a safety exclusion from a temporary restriction or a limitation of expected benefit.

Illustration comparing adipose coverage and muscular body contour
Look beyond the surface. Consider the muscular contour and its overlying adipose envelope when assessing the intended result. Select the image to open the full-size view.
Exclusion

Do Not Proceed

Identify conditions that prevent treatment under the applicable product instructions or the method’s clinical restrictions.

Explore the exclusions →
Temporary restriction

Defer Treatment

Establish why treatment should be postponed and what must change before a new clinical assessment can be considered.

Review temporary restrictions →
Individual assessment

Assess Suitability

Consider the medical context, previous treatments, tissue conditions and whether the intended contour change fits the existing anatomy.

Review the assessment →

The starting point: a clinical examination, a documented history and the current instructions for the exact preparation used.

Gluteal Myomodulation® · Clinical restrictions at a glance

In 30 Seconds

Defer — method protocol

Pregnancy & Breastfeeding

No elective treatment during pregnancy or breastfeeding under the protocol presented here.

Do not treat the affected site

Active Infection or Skin Disease

Defer injections in the affected area until the condition has been managed and reassessed.

Anatomical exclusion — method protocol

Superficial Gluteal Implant

Exclude treatment when the implant is too close to the skin surface. Implant removal alone does not establish later suitability.

Permanent exclusion — method protocol

Previous Biopolymer Complication

The method excludes patients with previous gluteal biopolymer complications, including after treatment of those complications.

Three-month restriction — method protocol

Recent Anabolic Steroid Use

The existing protocol excludes use within the preceding three months. Document the substance and timing; the interval alone is not clearance.

Excluded combination — method protocol

Peptonas

Do not combine the method with peptonas injections. Record previous exposure and associated complications.

Anatomical restriction

Already High Buttocks / Lumbar Dermolipectomy

Check the existing gluteal height and postoperative anatomy against the method’s lifting restrictions, particularly after dermolipectomy for major weight loss.

Limitation of visible benefit

Substantial Adipose Coverage

Overlying fat may conceal muscular reshaping. Assess expected contour visibility separately from medical contraindications.

Peanut Allergy — Gluteal Myomodulation®

In the clinical protocol described here, peanut allergy is not classified as an absolute contraindication to gluteal Myomodulation®. An allergic reaction remains possible, and the allergy history must be documented before treatment.

This guidance applies exclusively to the authentic Endopeel® formulation used for Myomodulation®. It does not apply to copies, imitations or substitute formulations.

“Method protocol” identifies restrictions stated on this clinical platform; it does not imply a universal contraindication for every gluteal procedure.

02 · General exclusions and temporary restrictions

General Contraindications

Exclusion during pregnancy — method protocol

Pregnancy

The protocol described here excludes elective gluteal Myomodulation® using the authentic Endopeel® formulation during pregnancy.

Decision: defer treatment. Reassess after pregnancy, taking breastfeeding status into account.

Exclusion during breastfeeding — method protocol

Breastfeeding

The protocol described here also excludes elective treatment during breastfeeding.

Decision: postpone until breastfeeding has ended and perform a new clinical assessment.

Temporary local restriction

Active Infection at the Injection Site

Do not inject through an infected area. Identify and manage the infection before reconsidering treatment.

Decision: defer treatment of the affected area until clinical resolution and reassessment.

Temporary local restriction

Active Skin Disease at the Injection Site

Active inflammatory lesions, erosions or open wounds within the planned injection area require assessment before treatment.

Decision: postpone injections through affected tissue until the condition has been managed and local suitability reassessed.

Inability to Provide Valid Informed Consent

Do not proceed when the patient cannot understand the proposed procedure, its risks and limitations, or cannot make a voluntary decision. A psychiatric diagnosis alone does not establish this exclusion.

03 · Restrictions specific to the gluteal region

Gluteal Restrictions

Anatomical exclusion — method protocol

Superficially Placed Gluteal Implant

A gluteal implant placed too close to the skin surface is an exclusion within the method described here.

Illustration accompanying the restriction for a superficially placed gluteal implant
Superficial implant placement. Select the image for the full-size view.

Decision: do not treat in this anatomical situation. If implant removal is clinically indicated, reassess healing and the residual anatomy before considering subsequent treatment.

Implant-specific restriction
Permanent exclusion — method protocol

Previous Biopolymer Complication

A history of gluteal biopolymer complications is a permanent exclusion within this method, even when the complication has been treated.

Existing clinical image accompanying the gluteal biopolymer restriction
Image accompanying the biopolymer restriction. Select for the full-size view.

Decision: exclude gluteal Myomodulation® under this protocol. Document the injected material, complications and previous management.

Biopolymer-specific restriction
Restriction on the lifting objective

Buttocks Already Placed Too High

An already high gluteal position is a restriction when the proposed treatment would further elevate the buttocks.

Decision: exclude further lifting in this configuration. Assess projection and contour objectives separately rather than assuming that every reshaping request requires elevation.

High-position restriction
Previous surgery — method restriction

Lumbar Dermolipectomy After Major Weight Loss

The existing protocol lists lumbar dermolipectomy following weight loss of more than 30 kg among its gluteal restrictions.

Record the operation performed and examine the postoperative gluteal position, scars and tissue displacement.

Decision: do not proceed with the routine lifting protocol in this listed situation. Establish the postoperative anatomy before discussing any alternative approach.

04 · Exposure history and excluded combinations

Anabolic Steroids & Peptonas

Three-month restriction — method protocol

Recent Anabolic Steroid Use

The gluteal Myomodulation® protocol described here excludes treatment when anabolic steroids have been used within the preceding three months.

Existing illustration accompanying the anabolic steroid restriction
Anabolic steroid exposure: document the substance and date of last use.

Record Before Planning

  • Substance used and route of administration.
  • Date of last use and duration of exposure.
  • Ongoing use or repeated cycles.
  • Prescribed treatment or nonmedical use.

Decision: defer treatment when exposure falls within the three-month exclusion period. After that interval, reassess suitability; elapsed time alone does not establish clearance.

This interval is a restriction of the method presented here, rather than a universal clearance rule for all anabolic substances. Changes to prescribed treatment must be coordinated with the prescribing physician.

Excluded combination — method protocol

Peptonas Injections

Do not combine gluteal Myomodulation® using the authentic Endopeel® formulation with injections marketed as “peptonas”.

If Previously Injected, Record

  • Name and available documentation of the injected preparation.
  • Injection dates and anatomical sites.
  • Previous local reactions or complications.
  • Persistent pain, itching, nodules or inflammation.

Decision: exclude the combination. Previous peptonas injections require assessment of the material used and the current tissue condition before considering another procedure.

Persistent symptoms or an uncertain injection history should be clarified before elective treatment is planned in the same area.

Read the peptonas restriction

05 · Limitation of visible benefit

Adipose Coverage & Result Visibility

Substantial overlying fat may conceal the change in muscular contour.

In the clinical approach described here, a thick gluteal adipose envelope can limit the visible result of Myomodulation®. The restriction concerns whether muscular reshaping translates into a useful change at the surface.

Decision: do not select the method for a contour objective that is expected to remain masked by adipose tissue. Assess the local tissue envelope and explain the limitation before proposing treatment.

Existing image accompanying the restriction related to substantial gluteal adipose coverage
Image accompanying the adipose coverage restriction. Select for the full-size view.

Assess Local Coverage

Evaluate the adipose envelope over the intended treatment area. Body weight or BMI alone does not describe how clearly a muscular contour change will be expressed at the gluteal surface.

Define the Isovolumetric Objective

The objective is reshaping and projection within the method’s isovolumetric concept. It should not be presented as a treatment for reducing the overlying fat.

Review the fundamental anatomical principles

06 · Allergy history and formulation-specific guidance

Peanut Allergy & Gluteal Myomodulation®

Position within the clinical protocol described here

Peanut allergy is not classified as an absolute contraindication to gluteal Myomodulation® within this protocol. An allergic reaction nevertheless remains possible.

Document the Allergy History

  • Nature and severity of previous peanut reactions.
  • Any history of anaphylaxis, respiratory symptoms or angioedema.
  • Previous reactions to the authentic Endopeel® formulation, including timing and management.

Do Not Equate This With Absence of Risk

The protocol classification is not a blanket clearance for every peanut-allergic patient. A previous severe reaction requires an individual assessment before elective treatment.

A claimed difference between facial and gluteal treatment should be supported by formulation-specific clinical evidence; the anatomical site alone does not establish allergy safety.

Authentic Endopeel® Formulation Only

Endopeel® denotes the specific formulation used for Myomodulation®. The guidance on this page applies exclusively to that authentic formulation. It does not apply to copies, imitations or substitute formulations.

07 · Before gluteal Myomodulation®

Pre-Treatment Clinical Checklist

  1. Pregnancy / Breastfeeding

    Confirm neither exclusion applies under the method protocol.

  2. Local Skin Condition

    Examine the injection area for infection, active skin disease, erosions or open wounds.

  3. Implants / Previous Injections

    Establish implant location and previous injected materials. Check for a superficial implant or a history of biopolymer complications.

  4. Previous Gluteal Surgery

    Record lumbar dermolipectomy and examine postoperative position, scars and tissue displacement.

  5. Anabolic Steroids / Peptonas

    Record the date of last anabolic steroid use and any peptonas injections. Apply the protocol’s three-month restriction and excluded combination.

  6. Allergy History

    Document peanut allergy, previous severe reactions and any reaction to the authentic Endopeel® formulation. Resolve significant allergy concerns before treatment.

  7. Height / Adipose Coverage

    Exclude an inappropriate further lifting objective and assess whether overlying fat would mask the intended muscular contour change.

  8. Consent / Intended Result

    Confirm valid informed consent and an objective consistent with isovolumetric reshaping and projection.

Record the Decision

Document any exclusion, reason for postponement or limitation of expected benefit. This focused checklist complements the full medical history and examination; it does not establish treatment eligibility by itself.

Clinical questions · Practical decisions

Focused Clinical FAQ

Answers to recurrent eligibility questions within the gluteal Myomodulation® protocol described on this page.

Does treating a biopolymer complication restore eligibility?

No. A previous biopolymer complication remains a permanent exclusion within this method, even if the complication has been treated.

Review gluteal restrictions
Does removal of a superficial implant automatically permit treatment?

No. Removal resolves the implant-related exclusion, but eligibility requires reassessment of the healed anatomy and remaining clinical restrictions.

Review implant-related restrictions
Is a high buttock position an exclusion for every objective?

The restriction concerns further lifting of already high buttocks. Projection or contour objectives require a separate anatomical assessment.

Review position and treatment objectives
What does substantial adipose coverage change?

It may conceal the muscular reshaping sought with this method. Assess local coverage and expected visibility rather than using body weight alone.

Review expected result visibility
Are three months without anabolic steroids sufficient for clearance?

No. Three months is the exclusion interval specified by this protocol, not automatic clearance. Record the last use and complete the clinical assessment.

Review anabolic steroids and Peptonas
Does peanut allergy automatically exclude gluteal Myomodulation®?

It is not classified as an absolute exclusion in the protocol described here. This does not establish individual safety: document the allergy history and assess reaction risk before deciding.

Review the formulation-specific allergy discussion

These answers concern the authentic Endopeel® formulation for Myomodulation®. They do not apply to copies, imitations or substitute formulations.

Clinical resources · Professional training

Continue Your Clinical Review

Review the technical framework, consult clinical support or explore practical training in gluteal Myomodulation®.

Anatomy & technique

Fundamental Basics

Review the three-dimensional isovolumetric framework: length, width and projection, with their implications for gluteal treatment planning.

Explore the principles

Method-specific guidance

Clinical Support

Consult the clinical support resources for questions about the authentic Endopeel® formulation, method-specific restrictions and clinical practice.

Access clinical support

Practical education

Myomodulation® Workshops

Explore the workshop programmes for practical training in assessment, anatomical planning and the Myomodulation® method.

Explore the workshops